Clinical Trial Update: Autologous Bone Marrow Mononuclear Stem Cell for Children Suffering From Liver Cirrhosis Due to Biliary Atresia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating autologous bone marrow mononuclear cells for children with biliary atresia–related liver cirrhosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Atresia
• Liver Cirrhosis

Drugs mentioned

• Autologous Bone Marrow Mononuclear Stem Cell Therapy (bone marrow mononuclear cells)

Snippet

Sponsor: Vinmec Research Institute of Stem Cell and Gene Technology | Conditions: Liver Cirrhosis, Biliary | Phase 2 | Status: COMPLETED